Shares of Life Science REIT plc (LON:LABS - Get Free Report) hit a new 52-week high on Monday . The company traded as high as GBX 48.60 ($0.66) and last traded at GBX 48.60 ($0.66), with a volume of 1630186 shares. The stock had previously closed at GBX 43.80 ($0.60).
Life Science REIT Price Performance
The stock has a market capitalization of £169.35 million, a PE ratio of -4.23 and a beta of 0.08. The business's fifty day moving average price is GBX 42.94 and its two-hundred day moving average price is GBX 39.71.
Life Science REIT (LON:LABS - Get Free Report) last issued its earnings results on Wednesday, April 16th. The company reported GBX 1.70 ($0.02) EPS for the quarter. Life Science REIT had a negative return on equity of 14.53% and a negative net margin of 198.99%.
About Life Science REIT
(
Get Free Report)
Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.
Further Reading
Before you consider Life Science REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.
While Life Science REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
